Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/25/2025

Treatment of Hypertriglyceridemia-Induced Pancreatitis

Acute Management

  • For patients with severe hypertriglyceridemia (≥1,000 mg/dL), the primary goal is to rapidly reduce triglyceride levels below 500 mg/dL to minimize risk of pancreatitis complications, according to the American College of Cardiology 1
  • Implement extreme dietary fat restriction (<5% of total calories as fat) until triglyceride levels decrease below 1,000 mg/dL, as recommended by the American College of Cardiology 1, 2
  • Completely eliminate alcohol and added sugars, as advised by the American College of Cardiology 1, 3

Long-Term Management

  • Fibrates are first-line agents for long-term management, with gemfibrozil (600 mg twice daily) or micronized fenofibrate (54-160 mg daily) being effective options, according to the American College of Cardiology 1, 5, 6
  • Omega-3 fatty acids (fish oils) may be used as alternative or adjunctive therapy, as suggested by the European Heart Journal 6, 7
  • Weight reduction for obese patients, regular aerobic exercise, and restriction of dietary fat are recommended lifestyle modifications, according to the Clinical Infectious Diseases journal 6, 4

Special Considerations

  • The American College of Cardiology recommends that statin plus fibrate combination may be needed for mixed dyslipidemia, but carries increased risk of myositis 10, 8
  • For patients with recurrent hypertriglyceridemia-induced pancreatitis, maintaining triglyceride levels <500 mg/dL long-term is crucial, and genetic testing may help personalize management in some cases, as noted by the Diabetes Care journal 5, 9

Monitoring

  • The European Heart Journal suggests monitoring triglyceride levels regularly to ensure they remain <500 mg/dL, and assessing for medication side effects, particularly myopathy with fibrate and statin combinations 7, 8
  • In diabetic patients, monitoring glucose levels closely, especially if on insulin or niacin therapy, is recommended by the Clinical Infectious Diseases journal 6

REFERENCES